APIM Therapeutics AS
Latest round
- Seed
Last raised
- Nov 2011
Total raised
- $0.5M
Investors
- 3
About APIM Therapeutics AS
Founded in 2009 in Trondheim, Norway, APIM Therapeutics AS specializes in peptide drug development for cancer treatments.APIM Therapeutics AS specializes in developing peptide drugs that target PCNA-dependent stress responses in cancer cells, particularly through its lead product, ATX-101. This drug aims to tackle critical mechanisms in cellular stress regulation and tumor evasion from therapy, undergoing clinical trials for ovarian cancer and sarcoma.APIM Therapeutics AS operates under a revenue model centered on partnerships and collaborations, typical in the biotech sector. Revenue is generated through licensing agreements, clinical trial partnerships, and potential product sales, with ATX-101 as a key offering. The company aims to expand its market presence in Europe and North America, focusing on providing advanced therapeutic options.
Who invested in APIM Therapeutics AS
3 investors across 3 rounds
See all investors in APIM Therapeutics AS
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about APIM Therapeutics AS
Who invested in APIM Therapeutics AS?
APIM Therapeutics AS has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has APIM Therapeutics AS raised?
APIM Therapeutics AS has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did APIM Therapeutics AS last raise money?
APIM Therapeutics AS's most recent round on record is a Seed, in Nov 2011.
What does APIM Therapeutics AS do?
Founded in 2009 in Trondheim, Norway, APIM Therapeutics AS specializes in peptide drug development for cancer treatments.
Where is APIM Therapeutics AS headquartered?
APIM Therapeutics AS is headquartered in Trondheim, Norway.
Which VCs invest in companies like APIM Therapeutics AS?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back pharmaceuticals companies at APIM Therapeutics AS's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like APIM Therapeutics AS? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.